hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.
Published April 19, 2017 · Recall initiated: March 8, 2017
Summary
FDA records drug Class II recall D-0668-2017, published April 19, 2017 and initiated March 8, 2017. Recalling firm: Mckesson Medical Surgical; Status: Terminated; Reported quantity: 98 vials; Lot: Lot #s: 6114311, 6114717, Exp 05/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
What to do
Voluntary: Firm initiated · Telephone
Get an email if HYDRALAZINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDRALAZINE HYDROCHLORIDE
- Manufacturer
- Mckesson Medical Surgical
- Distributor
- Nationwide in the USA
- UPC
- 0363323614003
- Lot
- Lot #s: 6114311, 6114717, Exp 05/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: AvetJanuary 3, 2024
- FDALumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDCApril 19, 2017
- FDABuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDCApril 19, 2017
- FDAESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles,April 19, 2017
- FDABuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottles (NDCApril 19, 2017
- FDAHydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured byAugust 19, 2015
Questions about this recall
Was hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc. recalled?
Yes. FDA published recall D-0668-2017 on April 19, 2017. Reported hazard: Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDRALAZINE HYDROCHLORIDE. UPC: 0363323614003.